Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia
Using CAR T cells for the treatment of acute lymphoblastic leukaemia
Myeloma bone disease: Clinical features and complications
Should you start treatment early in smouldering multiple myeloma?
Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease
Controversies in the management of prostate cancer
Role of interventional oncology for immunology treatment
First- and second-line treatments for locally advanced renal cell carcinoma
Advanced HCC: New systemic treatment options
Highlights from IGILUC 2019